Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Lifestyle Program For Patients With COPD Is Health And Cost Effective
Patients with moderate COPD were randomized to receive "usual care" or to undergo an interdisciplinary, community-based program (INTERCOM) that offered an intensive lifestyle moderation phase of four months, during which patients were instructed in detail to perform two 15-minute intervals of pleasurable walking or cycling, and offered instruction in other lifestyle changes such as nutrition and smoking cessation. After the four-month introductory period, there was a less intensive 20-month maintenance during which patients were offered guidance but not intensive intervention.

Anxiety And Depression Lower Quality Of Life In Majority Of Systemic Lupus Erythematosus Patients
92.8% of patients with systemic lupus erythematosus (SLE) suffer anxiety and depression which significantly affects both their physical and emotional quality of life (QoL), according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark. Logistic regression analysis revealed that depression was the most significant factor shown to affect QoL (p=0.015; OR=0.18; CI 95%:0.045-0.72).
News of the day
Cempra Pharmaceuticals Closes $46 Million Series C Financing
Cempra Pharmaceuticals, Inc., a clinical-stage company developing novel antibiotics for difficult-to-treat and drug-resistant infections, announced that it has successfully raised $46 million in a Series C financing. The funds will be used for the continued clinical development of CEM-101, Cempra"s lead macrolide compound; CEM-102, its promising oral antibiotic for gram-positive infections; and other preclinical stage, non-antibacterial macrolide programs. Quaker BioVentures led the Series C round, which also included Devon Park Bioventures, as well as original investors, Aisling Capital, Intersouth Partners, investment banker Wistar Morris III, and Teachers" Private Capital. Geeta Vemuri, Ph.D., Partner at Quaker BioVentures, will join the board with this financing.
Mental Health

Oncology Conference

Individuals interested in cancer research and disease management are invited to attend the 26th International Conference entitled, "Advances in the Applications of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells." This interdisciplinary conference is considered a keynote event in the biomedical research and biopharmaceutical industry. The event will take place June 22-24, 2009 at the Corfu Holiday Palace in Corfu, Greece, and will feature interactive presentations, unique open air workshops and expert discussions led by key opinion leaders in the field. Attendees will learn about the latest research developments and emerging cancer therapies. Natural Standard


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009